BioOrbit

Investor: LocalGlobe and Breega

BioOrbit, an in-space drug manufacturing company, has raised £9.8m in seed funding to accelerate its mission to manufacture pharmaceutical drugs in space at scale. Summary of transaction details: Value: £9.8m Sector: DeepTech & AI Advisor: Not disclosed Key Entities: BioOrbit, LocalGlobe, Breega Location: Not disclosed Note: This investment marks a significant milestone in the development of in-space manufacturing, enabling the production of high-value drugs at scale and in orbit for the first time, and has the potential to transform the pharmaceutical industry.